Dapagliflozin 5 Mg And 10 Mg Tablets 10 mg/200 mg/350 mg FC tablets
PDF Leaflet Revision Date: 19 September 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Improves glycaemic control in adults with type 2 diabetes mellitus.
Dosage (summary)
10 mg once daily, can be taken with or without food.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Increased risk of hypoglycaemia with insulin or sulphonylureas
- May enhance diuretic effects of thiazide and loop diuretics
Contraindications
- Type 1 diabetes
- Moderate to severe renal impairment
- Pregnancy and breastfeeding
- History of pancreatitis
Common side effects
- Genital infections
- Urinary tract infections
- Hypoglycaemia
- Dizziness
Counselling Points
- Monitor for signs of dehydration and hypotension
- Advise on routine foot care to prevent infections
- Inform about potential for urinary glucose excretion
Serious warnings
- Risk of metabolic acidosis and ketoacidosis
- Monitor renal function regularly
Important Disclaimer
The Dapagliflozin 5 Mg And 10 Mg Tablets 10 mg/200 mg/350 mg FC tablets professional information leaflet below is the property of Macleods Pharmaceuticals Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
